CBD and Women’s Health-Simply Explained
Published: npj Women's Health, August 2024 Researchers: Foria/Praxis Ventures funded study — 307 participants, quasi-experimental design
1. What Was Studied?
This study looked at whether a high-CBD vaginal suppository (100mg CBD, broad-spectrum hemp-derived) could reduce menstrual-related pain and discomfort in people who menstruate.
307 participants were assessed over two months using online questionnaires. 33 used the CBD suppository as their treatment. The remaining 230 continued their usual approach to managing menstrual symptoms (treatment as usual). Pre- and post-treatment symptom scores were compared between the two groups.
The researchers noted this was the first study involving a commercially available high-CBD suppository specifically for menstrual symptoms.
2. What Did They Find?
The CBD suppository group showed significantly greater improvement in symptoms over two months compared to the treatment-as-usual group
CBD appeared more effective for congestive symptoms — dull, aching pain accompanied by fatigue and mood changes — than for spasmodic symptoms like sharp cramps
The CBD group reported a meaningful reduction in how much their symptoms interfered with daily life, including avoiding activities
The CBD group also reduced their use of pain medications (analgesics) during the study period
There was a possible dose-dependent response — meaning more CBD may have produced greater effects, though this needs further study
3. What This Means
Menstrual pain is one of the most common reasons people reach for cannabis or CBD products — and yet clinical research in this area has been remarkably thin. This study is one of the first to look at a commercially available CBD product for this specific use, which makes it practically relevant in a way a lot of cannabis research isn't.
The finding that CBD worked better for dull, ongoing pain than sharp spasmodic cramps is useful nuance — it suggests CBD may be more appropriate for certain types of menstrual discomfort than others.
The reduction in painkiller use alongside symptom improvement is also worth noting — it suggests real-world functional benefit, not just a subjective sense of feeling better.
4. What This Does NOT Mean
This was a quasi-experimental study, not a randomized controlled trial — the comparison groups were not randomly assigned, which limits conclusions
The study was funded by the manufacturer of the product tested — an important consideration when evaluating results
This research does not apply to menopause or hormonal symptoms more broadly
Results may not apply to other CBD products, doses, or delivery methods
Larger, independent, randomized trials are needed to confirm these findings
5. Bottom Line
The first study of a commercially available CBD suppository for menstrual pain found meaningful symptom improvement and reduced painkiller use — but the study design has limitations that call for more rigorous follow-up research.
🗣️ Mary Jane's Take Women's health is one of the most under-researched areas in cannabis science. This study is a start, not a finish — but it's asking the right questions about a real reason people actually use CBD. The funding source is worth flagging, and the design isn't perfect, but the signal is interesting enough to watch.
